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The actions of diazepam and its p-chloro-derivative Ro 5-4864 were compared on mouse spinal cord and dorsal root ganglion neu- 
rons in cell culture. Diazepam enhanced but Ro 5-4864 reduced iontophoretic GABA responses in a concentration-dependent man- 
ner. Both diazepam and Ro 5-4864 limited sustained, high frequency repetitive firing of spinal cord neurons but diazepam was more 
potent. Ro 5-4864 was, however, more potent than diazepam in inhibiting spontaneous neuronal activity of spinal cord neurons and re- 
ducing the duration of calcium-dependent action potentials of dorsal root ganglion neurons. The differing actions of diazepam and Ro 
5-4864 may account for the contrasting pharmacological spectra of the two benzodiazepines. 
INTRODUCTION 
Benzodiazepines such as diazepam have a range of 
clinically useful effects including anxiolytic, anticon- 
vulsant, muscle relaxant and sedative-hypnotic ac- 
tions 9. However,  modifications of the benzodiaze- 
pine structure have been made in an attempt to de- 
velop benzodiazepines with a narrower,  more selec- 
tive spectrum of activity. One such benzodiazepine 
is Ro 5-4864 (7-chloro-l ,3-dihydro-l-methyl-5-(p- 
chlorophenyl)-2H-1,4-benzodiazepine-2-one),  the 
4'-chloro-derivative of diazepam 36. In the mid 1960's 
this compound aroused interest because its anticon- 
vulsant profile against experimental seizures in mice 
was unique for a benzodiazepine 36. Virtually all ben- 
zodiazepines, including diazepam, had been shown 
to have potent  anticonvulsant activity against penty- 
lenetetrazol (PTZ) seizures and less potent  activity 
against maximal electroshock (MES) seizures. In 
contrast, Ro  5-4864 had potent  anti-MES seizure ac- 
tivity but was virtually inactive against PTZ seizures. 
Ro 5-4864 and diazepam also have been shown to 
have rather different behavioral profilesS-7, 25, al- 
though they both were shown to have sedative ac- 
tions 625,36. Interest in Ro 5-4864 waned, however, as 
further studies in mice revealed that the compound 
had a paradoxical convulsant activity 36. Further- 
more, the anti-MES seizure activity could not be con- 
firmed in some studies24, 36. 
The bases for the different effects of diazepam and 
Ro 5-4864 are unclear. Diazepam and other anxiolyt- 
ic or anticonvulsant benzodiazepines have been 
shown to enhance G A B A  responses3.9,17, presum- 
ably by binding to high affinity benzodiazepine re- 
ceptors and to have no effect on glutamate re- 
sponses 15. Ro 5-4864, however, only very weakly in- 
teracts with high affinity benzodiazepine binding 
sites 33. Specific binding sites in the brain, spinal cord 
and peripheral tissues have been reported for [3H]Ro 
5-4864 (refs. 4, 21, 27, 28 and 32), but these sites have 
marked pharmacological and thermodynamic differ- 
ences from 'classical' benzodiazepine receptors28,32. 
Thus, it is likely that diazepam and Ro  5-4864 have 
different actions on GABAerg ic  inhibition. 
To understand more completely the mechanisms 
of action of 'classical' and atypical benzodiazepines, 
we have investigated the actions of Ro 5-4864 and di- 
azepam upon mouse spinal cord and dorsal root  gan- 
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glion neurons in cell culture. First, we have com- 
pared the actions of diazepam and Ro 5-4864 on 
GABA and glutamate responses evoked on spinal 
cord neurons. Second, we have investigated the ac- 
tion of the benzodiazepines on sustained, high fre- 
quency repetitive firing in spinal cord neurons. We 
have previously shown that several anticonvulsants 
which are also effective against MES seizures, in- 
cluding phenytoin and carbamazepine, reduced sus- 
tained high frequency repetitive firing14,19.z0. Finally, 
we have studied the effects of diazepam and Ro 
5-4864 on spontaneous activity and calcium-depend- 
ent action potential duration. We have shown that re- 
duction of spontaneous activity and calcium-depend- 
ent action potential duration by anticonvulsants, in- 
cluding phenobarbital and phenytoin, correlates with 
reduction of presynaptic calcium uptake and reduc- 
tion of synaptic transmission and may be a sedative/ 
anesthetic action 10.14. 
MATERIAL AND METHODS 
Spinal cords with attched dorsal root ganglia were 
dissected from 12-14 day old mouse embryos and 
dissociated to a cell suspension. The spinal cord and 
dorsal root ganglion neurons were then maintained in 
cell culture as earlier described 26. Neurons (5-8 
weeks in vitro) were penetrated under visual gui- 
dance on the modified stage of an inverted phase- 
contrast microscope with high impedance (25-50 
MQ) glass micropipettes. Using a conventional 
bridge circuit, simultaneous current injection and 
membrane potential measurement were possible 
with a single micropipette. Spinal cord and dorsal 
root ganglion neurons could be identified unambigu- 
ously by visual and electrophysiological criteria 26. 
Data were recorded on a Gould (2600S) polygraph or 
by filming of oscilloscope records. For assessment of 
spontaneous neuronal activity, repetitive firing and 
responses to iontophoretically applied S-glutamate, 
recording micropipettes were filled with 4 M potassi- 
um acetate (KAc). Three M potassium chloride 
(KCI) filled micropipettes were used to study GABA 
responses, while 4 M cesium acetate (CsAc) filled 
micropipettes were used to study calcium-dependent 
action potentials. In most experimentsa Dulbecco's 
phosphate buffered saline was used as the recording 
medium (NaCI 143.4 mM, KC1 4.2 mM, CaC12 0.9 
mM, MgCI 2 0.9 mM and glucose 5.6 mM in 9.5 mM 
sodium phosphate buffer, pH 7.35-7.40). For studies 
of amino acid responses or repetitive firing, back- 
ground spontaneous activity was suppressed by el- 
evation of the magnesium ion concentration to 10 
mM. For calcium-dependent action potential studies, 
a 13 mM Tris buffer containing NaCI 137.0 mM, KCI 
5.3 raM, CaC12 5.0 mM, MgCI 2 0.8 mM, tetraethy- 
lammonium (TEA) chloride 5.0 mM and 5.6 mM glu- 
cose, at pH 7.30, was used. Amino acid and calcium- 
dependent action potential experiments were per- 
formed at 33-34 °C, while spontaneous activity and 
repetitive firing experiments were performed at 
36-37 °C. 
Depolarizing steps of 450 ms duration were used to 
elicit repetitive firing in spinal cord neurons; drugs 
were bath applied following the demonstration of 
sustained repetitive firing in at least 3 control cells in 
each culture studied. Spontaneous activity in neuro- 
nal populations was determined over a 3 min period 
in each cell and was graded according to the arbitrary 
5 point scale shown in Fig. 5 (see ref. 18 for more de- 
tailed explanation). For iontophoresis, GABA (0.5 
M, pH 3.2) or S-glutamate (0.5 M, pH 10.0) were ap- 
plied using 400 ms duration rectangular current 
pulses (GABA up to +20 nA, S-glutamate up to -60 
nA) at 4 s intervals. Benzodiazepines or vehicle 
(0.1% or less dimethyisulfoxide) were simulta- 
neously applied by miniperfusion (0.2 psi ejection 
pressure, 30 s pulses) from a blunt tipped (5-10 ~m) 
micropipette positioned 15-50/~m from the soma of 
the cell under study. Vehicle alone did not alter ami- 
no acid responses, repetitive firing, or action poten- 
tial duration. Since dirnethylsuifoxide weakly sup- 
pressed spontaneous activity, paired concentration 
vehicle controls were run in all experiments. Ionto- 
phoretic currents were adjusted to obtain amino acid 
responses of 6-9 mV amplitude, and data were ac- 
cepted only if the responses returned to control am- 
plitude within 5 min of removal of the benzodiaze- 
pine-containing micropipette. 
In some experiments the interaction between ben- 
zodiazepines and the benzodiazepine antagonist Ro 
15-1788 n was investigated. Ro 15-1788 was applied 
by diffusion from large tipped (10-20/~m) micropi- 
pettes, diazepam and Ro 5-4864 by miniperfusion, 
and GABA by iontophoresis. After a diazepam or 
Ro 5-4864 effect was obtained on a GABA response, 
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Fig. 1. A: differing effects of diazepam (100 nM, At, membrane potential, MP = -82 mV) and Ro 5-4864 (10/~M, A2, MP = -83 mV) 
on GABA responses of spinal cord neurons. B: Ro 15-1788 (1/~M) weakly enhanced GABA responses and blocked further en- 
hancement by 100 nM diazepam (B1, MP = - 75 mV) while failing to alter inhibition by 10 pM Ro 5-4864 (B2, MP = -80 mV). C: glu- 
tamate responses were unaltered by 1/~M diazepam (CI, MP = -71 mV) or by 10 #M Ro 5-4864 (C2, MP = -60 mV). Recordings 
were with 3 M KCl-filled micropipettes. Time of amino acid application is indicated by horizontal bars below amino acid responses. 
a micropipette containing Ro  15-1788 was positioned 
near (20-50/~m) the tip of the G A B A  pipette. Diaze- 
pam or Ro 5-4864 was then reapplied. After  a stable 
effect on the G A B A  response was achieved, both 
agonist and antagonist micropipettes were removed 
and control G A B A  responses were recorded. Data  
were accepted only if G A B A  responses evoked prior 
to and following benzodiazepine applications were 
equivalent. 
Membrane potentials of dorsal root ganglion neu- 
rons were maintained at about -60  mV, and 500/~s 
depolarizing current pulses (frequency 4 Hz) were 
used to evoke calcium-dependent action potentials. 
Blockade of voltage-dependent potassium conduc- 
tances by extraceilular T E A  and intracellular injec- 
tion of cesium ions enhanced the duration of  the cal- 
cium component  of the action potential so that it was 
100-1000 times that of the sodium component .  Fol- 
lowing stabilization of action potential duration, ben- 
zodiazepines were applied by pressure ejection (0.8 
psi, 3 -5  s before the action potential was evoked. 
Data  were accepted only if action potential duration 
returned to the control values within 2 min of  remov- 
al of the drug-containing micropipette. 
RESULTS 
Diazepam (>  1 nM) reversibly enhanced G A B A  
responses of spinal cord neurons (Fig. 1A1) in a con- 
centration-dependent manner,  with 20% en- 
hancement  at 10 nM and 80% enhancement  at 100 
nM (Fig. 2, filled circles). In contrast, Ro 5-4864 re- 
versibly inhibited G A B A  responses (Fig. 1A2) in a 
concentration dependent manner,  with 9% inhibi- 
tion at 100 nM, 24% inhibition at 1 # M  and 58% inhi- 
bition at 10 ~M (Fig. 2, filled squares). The benzo- 
diazepine antagonist Ro  15-178811 (1 /~M) blocked 
the enhancement of G A B A  responses by diazepam 
(100 nM) (Fig. 1B1), but Ro  15-1788 did not alter the 
inhibition of G A B A  responses by Ro 5-4864 (10 ~M) 
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Fig. 2. Concentration-dependence of diazepam (circles) and 
Ro 5-4864 (squares) effects upon G A B A  responses of spinal 
cord neurons. Data shown are the means + S.E.M. of re- 
sponses from 7 or more neurons for each drug and concentra- 
tion tested. Benzodiazepine concentrations shown on the 
abscissa are logarithm molar. 
(Fig. 1B2). Neither diazepam (1/~M) (Fig. 1C1) nor 
Ro 5-4864 (10/~M) (Fig. 1C2) altered responses of 
spinal cord neurons to S-glutamate (diazepam re- 
sponses, 98.8 + 1.0% control, n = 10 neurons; Ro 
5-4864 responses, 97.4 + 1.2% control, n = 5 neu- 
rons). Similarly, resting membrane potential and 
conductance were unaltered by diazepam (0.1 
nM-10 pM) or Ro 5-4864 (10 nM-10 pM) in spinal 
cord neurons (KAc or KC1 impalements) and in dor- 
sal root ganglion neurons (CsAc impalements). 
Injection of a depolarizing pulse of sufficient mag- 
nitude into spinal cord neurons elicits sustained, high 
frequency repetitive firing (see control cell, Fig. 3). 
Diazepam and Ro 5-4864 limited repetitive firing in a 
dose-dependent manner. At 87.5 nM, diazepam lim- 
ited repetitive firing to one or a few action potentials 
in half the neurons tested, while 6 of 7 neurons were 
limited at 175 nM diazepam (Fig. 3). Ro 5-4864 limit- 
ed repetitive firing in 5 of 7 neurons at 500 nM and 9 
of 10 neurons at 10pM. 
Spontaneous activity of spinal cord neurons was 
limited by both diazepam and Ro 5-4864 (Figs. 4 and 
5) with Ro 5-4864 being more potent, significantly in- 
hibiting activity (reduction of activity grade, see 
Fig. 5) at 500 nM and greater. Diazepam only signifi- 
cantly inhibited activity at 10 pM; at this concentra- 
tion Ro 5-4864 produced quiescence in all 15 neurons 
studied. Action potentials could still be evoked in all 
quiescent neurons. In contrast, another GABA anta- 
gonist, picrotoxin, produced paroxysmal depolari- 
zing events (grade 5 activity) at 100 pM in each neu- 
ron. 
Diazepam had insignificant effects on the duration 
of dorsal root ganglion neuron calcium-dependent 
action potentials at 100 nM (94.4 +_ 2.1% control, 8 
neurons) and at l p M  (93.8 + 2.6% control, 11 neu- 
rons) (Fig. 6). At 10/~M diazepam shortened calci- 
um-dependent action potential duration by 16.2 + 
3.6% (11 neurons). Ro 5-4864 had only minor effects 
at 1/~M (8.3 + 2.0% shortening, 6 neurons) while re- 
ducing calcium-dependent action potential duration 
by 24.6 _+ 2.6% at 10/~M (10 neurons) (Fig. 6). 
DISCUSSION 
In the present study we have shown that diazepam 
enhanced but Ro 5-4864 depressed GABA responses 
while neither benzodiazepine modified glutamate re- 
sponses. Diazepam presumably enhanced GABA re- 
sponses by binding to high affinity benzodiazepine 
receptors, but at what receptors did Ro 5-4864 act to 
antagonize G A B A  responses? It is unlikely that Ro 
5-4864 antagonized GABA responses by binding to 
the GABA recognition site since Ro 5-4864 has not 
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Fig. 3. Limitation of sustained, high frequency repetitive firing 
of spinal cord neurons by diazepam and Ro 5-4864. Data are 
expressed as % of neurons exhibiting sustained, high frequency 
repetitive firing at each drug concentration (numbers of cells 
studied at each concentration shown in brackets). Control 
(drug free) cell populations are shown as hatched bars (C). 
Sample photographed oscilloscope traces are shown at right. 
These traces were recorded from neurons with resting mem- 
brane potentials o f - 6 0  to -70 mV, which were stimulated with 
intracellular depolarizing current pulses of 1.5-2.0 nA and 450 
ms duration. The panels shows the greatest  number of action 
potentials elicited by one of a series of depolarizing current 
pulses. 
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Fig. 4. Effects of diazepam and Ro 5-4864 on spontaneous ac- 
tivity of spinal cord neurons. Membrane potentials of cells were 
maintained at-55 to -70 mV. 
been shown to inhibit [3H]GABA binding 3°. Further- 
more,  the effect of Ro 5-4864 is unlikely to be due to 
binding to high affinity benzodiazepine receptors 
since the effect was not influenced by the benzodia- 
zepine antagonist Ro  15-1788. It is unlikely that Ro 
5-4864 antagonized G A B A  responses by binding to 
the high affinity 'peripheral '  type benzodiazepine re- 
ceptor. The high affinity binding sites for Ro  5-4864 
in brain and peripheral tissues have dissociation con- 
stants of 1-10 nM, while in the present studies, Ro 
5-4864 had no effect on G A B A  responses below 100 
nM although this concentration would almost fully 
saturate the high affinity Ro 5-4864 binding sites27, 32. 
It has been suggested that the nanomolar  Ro  5-4864 
sites may be non-neuronal  and located on glial cells 
since high densities of [3H]Ro 5-4864 binding sites 
were found on glial cell linesS.lS.30 and striatal kainic 
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Fig. 5. Concentration-dependence of diazepam and Ro 5-4864 
effects upon spontaneous activity of spinal cord neurons. Re- 
suits with the convulsant GABA antagonist picrotoxin (PTX) 
are shown for comparison. Bars show mean grade + S.E.M. of 
activity, graded according to the scale shown at right (see ref. 
19 for details). Control bars (C) are hatched. Numbers in par- 
entheses represent the number of cells studied. Asterisks indi- 
cate a statistically significant difference from control grade (P 
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Fig. 6. Effects of diazepam and Ro 5-4864 upon calcium-de- 
pendent action potentials in dorsal root ganglion neurons. Re- 
touched oscilloscope traces from representative cells are 
shown. 
acid lesions, which produced marked glial prolifer- 
ation, resulted in up to 10-fold increases in [3H]Ro 
5-4864 binding27. Ro 5-4864 has been shown to also 
interact with a lower (micromolar) affinity site in syn- 
aptosomal membranes1,27,32 and recently, autoradio- 
graphic techniques have revealed a lower affinity, 
low density [3H]Ro 5-4864 binding site in brain sec- 
tions 21. The results of the present study suggest that 
Ro 5-4864 receptors on spinal cord neurons are of ap- 
parent micromolar affinity and are, at least in part, 
negatively coupled to G A B A  receptors. In these re- 
spects, Ro  5-4864 actions are likely distinct from 
those of the inverse agonist D M C M  (methyl 6,7-di- 
methexy-4-ethyl-fl-carboline-3-carboxylate) which is 
a potent inhibitor of benzodiazepine binding and also 
inhibits G A B A  responsesL It is of interest that maxi- 
mal enhancement of G A B A  responses was produced 
at about 10 nM and that higher diazepam concentra- 
tions produced less enhancement.  It is possible that 
the reduction of diazepam enhancement at high nano- 
molar concentrations is due also to an interaction 
with the low affinity receptor. 
These results may explain some of the differing be- 
havioral actions of  the two benzodiazepines. Con- 
centrations of diazepam with activity against anxiety 
and generalized absence seizures in man and PTZ 
seizures in mice are likely to be low nanomolar  in the 
cerebrospinal fluid 12. Thus, diazepam may have anx- 
iolytic and anti-PTZ seizure activity because it en- 
hances GABAerg ic  inhibition. In contrast, Ro 
5-4864 has no anti-PTZ activity and may be anxio- 
genic and convulsant because it antagonized postsyn- 
aptic GABAerg ic  inhibition. These conclusions are 
supported by studies of  non-benzodiazepine anticon- 
vulsants and convulsants. Barbiturates, which are an- 
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tagonists of PTZ seizures, also enhance G A B A  re- 
sponses17,22, 29, while phenytoin and carbamazepine, 
which are inactive against PTZ seizures, do not en- 
hance GABA responses at therapeutic concentra- 
tions14,19. Furthermore, compounds such as bicucui- 
line, picrotoxin, PTZ and penicillin, which antago- 
nize GABA responses 16, are convulsants. 
We have also shown that diazepam and Ro 5-4864 
limit sustained, high frequency repetitive firing. 
However, diazepam was less potent in limiting repet- 
itive firing than in enhancing GABA responses and 
has been shown to be less potent against MES sei- 
zures than against PTZ seizures 36. Other studies have 
demonstrated that drugs with activity against MES 
seizures (e.g. phenytoin and carbamazepine) limit 
sustained, high frequency repetitive firing of spinal 
cord neurons in cell culture at therapeutic cerebro- 
spinal fluid concentrations19, 20. Thus, it is possible 
that diazepam has anti-MES seizure activity, at least 
in part, due to its ability to limit sustained, high fre- 
quency repetitive firing. Ro 5-4864 also limited sus- 
tained, high frequency repetitive firing. However, it 
is not clear that Ro 5-4864 has anti-MES seizure ac- 
tivity at non-convulsive doses 6,24,35,36. This may be 
due to the overlapping dose dependencies of Ro 
5-4864 action on G A B A  responses and repetitive fir- 
ing. Ro 5-4864 inhibited GABA responses at 100 nM 
while reducing repetitive firing only above 100 nM. 
Thus, convulsant action may occur at concentrations 
below those required for anticonvulsant action. 
In the present study, we have shown also that Ro 
5-4864 and diazepam decreased calcium-dependent 
action potential duration in dorsal root ganglion neu- 
rons and spontaneous activity in spinal cord neurons, 
but that Ro 5-4864 was more potent. Calcium-de- 
pendent action potential shortening and reduction of 
spontaneous activity both were produced by Ro 
5-4864 at or above 500 nM but by diazepam at or 
above 10/tM. Nanomolar concentrations of diaze- 
pam have been shown to enhance potassium stimu- 
lated calcium uptake 23, but 100 nM diazepam had 
little effect on calcium-dependent action potential 
duration in the present experiments. Micromolar 
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